1EXEL:BIT
Exelixis Inc
€45.90
arrow_downward
-10.04%(-5.12) 1D
Aug 18, 4:34:09 PM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 1EXEL...
Mkt. cap
14.62B
Avg. vol.
1.00
Volume
0.00
52-wk high
€51.02
52-wk low
€29.27
No. of employees
1K
Mkt. cap
14.62B
Avg. vol.
1.00
Volume
0.00
52-wk high
€51.02
52-wk low
€29.27
No. of employees
1K
News stories
From web sources and news partners
Investor's Business Daily
·
1 day ago
IBD Stock Of The Day Exelixis Hits Earnings Snag — And Then Breaks Out
Yahoo Finance
·
1 day ago
Exelixis (EXEL) Up 13.3% Since Last Earnings Report: Can It Continue?
Investor's Business Daily
·
3 days ago
Cancer Stock Breaks Out To Highs; Key FDA Action On Watch
Investing.com
·
3 days ago
Exelixis stock hits all-time high at 57.68 USD
Profile
Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration for medullary thyroid cancer with clinical activity in several other types of metastatic cancer. Wikipedia
About Exelixis Inc
CEOMichael M. Morrissey
Employees1.08K
FoundedNov 15, 1994
HeadquartersAlameda, California, United States
SectorBiotechnology
Websiteexelixis.com